The invention concerns a method for the treatment of neuropathic pain and particularly acute neuropathic pain.

Preferably, the chronic pain comprises a neuropathic pain.

The neuropathic pain may be diabetic neuropathy.

The neuropathic pain may be diabetic neuropathy.

The present invention relates to the use of a combination of cannabinoids in the treatment of neuropathic pain, in particular peripheral neuropathic pain.

The present invention makes available a pre-clinical model of neuropathic pain which permits the identification of compounds with enhanced analgesic efficacy for neuropathic pain.

The neuropathic pain may be painful diabetic neuropathy.

Disclosed is a therapeutic agent for neuropathic pain having an excellent therapeutic effect on neuropathic pain which is a intractable disease.

Provided herein are compounds and pharmaceutical compositions for use in the treatment of neuropathic pain and the neuropathic pain syndromes.

Nerve pain (called neuropathic pain), is one of the more difficult and uncomfortable types of pain.

The pain may, for example, be neuropathic pain, inflammatory j pain or pain associated with cancer (other than neuropathic pain), surgery, visceral damage, headache or trauma.

Neuropathic pain, which is more commonly referred to as nerve pain, is among the more uncomfortable and complex types of pain.

Therefore, the composition of the present invention is effective for the alleviation of peripheral neuropathic pain.

Neuropathic pain (neuralgia) is a pain that comes from problems with signals from the nerves.

Such treatable pain includes visceral pain, neuropathic pain and hyperalgesia.